Botanix Pharmaceuticals Limited’s Acquisition of Sofpironium Bromide

Martina Bellini North America Legal Chronicle
Tagged:

Troutman Pepper advised Botanix Pharmaceuticals Limited on the deal.Botanix Pharmaceuticals Limited (ASX: BOT), a clinical dermatology company, has announced the acquisition of Sofpironium Bromide gel, 15%,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here